In Brief: FDA journal reprints/textbook dissemination guidance
This article was originally published in The Tan Sheet
Executive Summary
FDA journal reprints/textbook dissemination guidance: Final guidance, published in the Oct. 8 Federal Register, remains virtually unchanged from the draft guidance issued last December. The agency says it reviewed over 57 comments on the draft and "determined that no changes need to be made." The guidance permits industry-sponsored dissemination of articles from peer-reviewed journals that describe efficacy studies used for agency approval...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning